1. Home
  2. AMPH vs TWO Comparison

AMPH vs TWO Comparison

Compare AMPH & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • TWO
  • Stock Information
  • Founded
  • AMPH 1996
  • TWO 2009
  • Country
  • AMPH United States
  • TWO United States
  • Employees
  • AMPH N/A
  • TWO N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • TWO Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • TWO Real Estate
  • Exchange
  • AMPH Nasdaq
  • TWO Nasdaq
  • Market Cap
  • AMPH 1.6B
  • TWO 1.3B
  • IPO Year
  • AMPH 2014
  • TWO 2009
  • Fundamental
  • Price
  • AMPH $31.28
  • TWO $13.77
  • Analyst Decision
  • AMPH Buy
  • TWO Buy
  • Analyst Count
  • AMPH 4
  • TWO 8
  • Target Price
  • AMPH $50.33
  • TWO $14.04
  • AVG Volume (30 Days)
  • AMPH 479.2K
  • TWO 1.2M
  • Earning Date
  • AMPH 03-03-2025
  • TWO 01-29-2025
  • Dividend Yield
  • AMPH N/A
  • TWO 13.08%
  • EPS Growth
  • AMPH 17.38
  • TWO N/A
  • EPS
  • AMPH 3.01
  • TWO 2.37
  • Revenue
  • AMPH $723,549,000.00
  • TWO $622,055,000.00
  • Revenue This Year
  • AMPH $16.22
  • TWO N/A
  • Revenue Next Year
  • AMPH $4.27
  • TWO N/A
  • P/E Ratio
  • AMPH $10.39
  • TWO $5.80
  • Revenue Growth
  • AMPH 20.33
  • TWO 130.86
  • 52 Week Low
  • AMPH $30.34
  • TWO $10.84
  • 52 Week High
  • AMPH $56.38
  • TWO $14.27
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 25.63
  • TWO 76.81
  • Support Level
  • AMPH $30.34
  • TWO $13.45
  • Resistance Level
  • AMPH $32.40
  • TWO $13.67
  • Average True Range (ATR)
  • AMPH 0.87
  • TWO 0.19
  • MACD
  • AMPH 0.01
  • TWO 0.07
  • Stochastic Oscillator
  • AMPH 23.21
  • TWO 91.10

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust primarily focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. Most of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

Share on Social Networks: